Epirubicin hydrochloride injection 10 mg in 5 mL (8)

Land: Australia

Språk: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Aktiv ingrediens:

epirubicin hydrochloride, Quantity: 2 mg/mL

Tilgjengelig fra:

Pfizer (Perth) Pty Ltd

Legemiddelform:

Injection, solution

Sammensetning:

Excipient Ingredients: sodium chloride; hydrochloric acid; water for injections

Administreringsrute:

Intravenous Infusion, Intravesical

Enheter i pakken:

1 X 5 mL

Resept typen:

(S1) This Schedule is intentionally blank

Indikasjoner:

? breast cancer; ? malignant lymph node tumours (lymphoma); ? soft tissue tumours (sarcomas); - cancer of the stomach and intestine (sigmoid rectal cancer) ? liver cancer; ? pancreatic cancer; ? cancer of the head or neck (cervical and facial segment) ? lung cancer; ? ovarian cancer; ? blood cancer (leukaemia). Farmorubicina 10 mg/5 ml e 50 mg/25 ml is also administered directly into the bladder (intravesical route), in the treatment of early (superficial) bladder cancer and to prevent bladder cancer relapse after surgery (transurethral resection).

Produkt oppsummering:

Visual Identification: Clear and clean red solution; Container Type: Vial; Container Material: PP; Container Life Time: 36 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Autorisasjon status:

Listed (Export Only)

Autorisasjon dato:

2019-01-31